The leading cause of death worldwide is cardiovascular disease. In addition to the known factors leading to CVD, in recent years much attention has been paid to obesity as one of the components of cardiometabolic syndrome. In this case, visceral obesity serves the development of various heart pathologies, leading to myocardial ischemia, the appearance of cardiac arrhythmias, as well as the progression or development of chronic heart failure. In addition to the typical sites of fatty tissue deposition, there is an area of accumulation that directly contributes to the progression of CVD - epicardial fat (EAT). Normally, EAT serves as a mechanical barrier and protects the heart from external influences. However, when it accumulates excessively, a meta-inflammatory process occurs, similar to that which develops in adipose tissue of any localization, leading to the release of proinflammatory cytokines and disruption of endothelial dysfunction, thereby being a trigger for destabilization.
| Mualliflar | Ким , A, Срожидинова , Н, Шек, А, Фозилов , Х, Kim , Andrey, Srojidinova , Nigora, Shek , Aleksandr, Fozilov, Khurshid, Kim , Andrey, Srojidinova , Nigora, Shek , Aleksandr, Fozilov, Хurshid |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2024-03-30 |
| Jild | 1 |
| Son | 1 |
| Betlar | 69-76 |
| Til | Rus |
| DOI | 10.70626/cardiouz-2024-1-00009 |
DOI: 10.70626/cardiouz-2024-1-00009 · Maqolaning asl sahifasi
epicardial fat (EAT), echocardiography, cardiovascular diseases (CVD), inflammation, эпикардиальный жир (ТЭЖ), ЭхоКГ, сердечно-сосудистые заболевания (ССЗ), воспаление, epikardial yog' qatlami (EYoQ), ExoKG, yurak-qon tomir kasalliklari (YQTK), yallig‘lanish
Background. The COVID-19 pandemic has posed significant health risks, particularly for elderly patients. Studies on the impact of COVID-19 in this age group have highlighted various atypical clinical manifestations…
Background. Peripartum cardiomyopathy (PPCM) is a rare yet serious condition affecting women during late pregnancy or the postpartum period, often leading to complications such as ventricular arrhythmias and…
Background. Sodium-Glucose Cotransporter-2 (NGLT-2) inhibitors have gained significant attention for their cardioprotective properties. This review explores the cardiovascular benefits of NGLT-2 inhibitors…
Abstract. Contrast-induced nephropathy (CIN) represents a significant clinical challenge, particularly among patients diagnosed with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). The increased…
Background. To study the characteristics of the clinical course of arterial hypertension by gender in the population of the Aral Sea region and to strengthen effective preventive measures. Materials and methods. The…
Arterial hypertension is a widely prevalent condition affecting millions of people worldwide. According to the World Health Organization (WHO) data, in 2021, more than 1 billion people suffered from hypertension. The…
Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. Coronary artery disease (CAD) accounts for one third of all deaths from the diseases of the…
Background. Atherosclerosis is a leading cause of cardiovascular mortality worldwide, significantly impacting public health. microRNA, as key regulators of gene expression, play a crucial role in the pathogenesis of…
Background. Postoperative atrial fibrillation (POAF) is a common complication in patients undergoing coronary artery bypass grafting (CABG), which significantly affects recovery and increases the risk of adverse…
Background. This study explores the impact of anxiety and depressive disorders on the rehabilitation outcomes and long-term prognosis of patients with acute myocardial infarction (AMI) and unstable angina. The aim is to…